MedservRegis Plc

Major Shareholding Notification • Apr 30, 2018

COMPANY ANNOUNCEMENT

MEDSERV P.L.C. (THE "COMPANY")

Major Shareholders' Intention to Source Strategic Purchaser & Disclosure of Unpublished Price Sensitive Information

Date of Announcement	30 April 2018
Reference	168/2018
Listing Rule	LR 5.16.18, LR 5.174

The Board of Directors of the Company announces that its two major shareholders, that is, Anthony S. Diacono (holding 31.17% of the Company's issued share capital and also an Executive Director) and Malampaya Investments Limited, the beneficial owner of which is Anthony J. Duncan (holding 34.33% of the Company's issued share capital and also an Executive Director) (together the "Major Shareholders"), have informed the Board of Directors that they intend to source a strategic purchaser to acquire their shareholding in the Company. The sale may refer to all or part of the Major Shareholders' holdings in the Company.

The Major Shareholders are confident that, with its strong business pipeline, the Group is well placed to secure current and prospective business opportunities. Having said that, they are of the view that sourcing a strategic purchaser should accelerate and further supplement the Group's growth and internationalisation strategy. This is a view also shared by the Board of Directors of the Company.

The Board is informed that the process is a very early stage and there is no certainty that a suitable purchaser will be found or that negotiations will once commenced be successful.

In line with their stated intention, the Major Shareholders have also requested that the Company obtains the authority, originally provided by the shareholders at the extraordinary general meeting of the 12 October 2015, pursuant to which the Company was authorized to disclose to any bona fide offeror such information in relation to the Medserv group of companies, including unpublished price-sensitive information, as may be necessary to enable any bona fide offeror and its advisers to make, confirm, withdraw or modify any bona fide offer made for a substantial shareholding in the Company.

Accordingly, the Major Shareholders have formally requested the Board to place the following item on the agenda of the annual general meeting scheduled to take place on the 28 May 2018:

QUOTE

Special Business – Ordinary Resolution

That, subject to the terms and conditions set out in Listing Rule 5.174, the Company be authorised to disclose to any bona fide offeror and the corresponding transferor such information in relation to the Medserv group of companies, including unpublished pricesensitive information, as may be necessary to enable any bona fide offeror, bona fide transferor and their advisers to make, confirm, withdraw or modify any bona fide offer made to purchase and acquire a substantial shareholding in the Company.

UNQUOTE

Laragh Cassar Company Secretary